HF
TRIB

HRT Financial’s Trinity Biotech TRIB Stock Holding History

HRT Financial’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,208
Closed -$37K – 3527
2025
Q1 		$37K Buy
+2,208
New +$52.3K ﹤0.01% 2261
2024
Q4 		– Sell
-1,134
Closed -$37K – 3254
2024
Q3 		$37K Buy
+1,134
New +$76.6K ﹤0.01% 2140
2021
Q4 		– Sell
-90
Closed -$29K – 4081
2021
Q3 		$29K Sell
90
-4
-4% -$1.41K ﹤0.01% 3113
2021
Q2 		$41K Hold
94
– – ﹤0.01% 2688
2021
Q1 		$53K Buy
+94
New +$67.8K ﹤0.01% 2535
2020
Q4 		– Sell
-261
Closed -$78K – 2473
2020
Q3 		$78K Buy
261
+96
+58% +$33.3K ﹤0.01% 1587
2020
Q2 		$53K Buy
+165
New +$37.7K ﹤0.01% 1310

Other funds holding TRIB

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.6B AUM 28.24% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
WN
Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
BCM
Becker Capital Management Portland, Oregon $3.72B AUM 31.98% 1-Year Est. Return

HRT Financial's TRIB Position: Q2 2025 in Review

HRT Financial sold out of Trinity Biotech (TRIB) in Q2 2025, closing a stake of 2,208 shares — an estimated $37K sold.

HRT Financial first reported a position in TRIB in Q2 2020 and held it in 7 quarters. The position peaked at $78K in Q3 2020. 21 funds tracked by Wall St. Rank hold TRIB as of Q2 2025.

  • HRT Financial reported no remaining Trinity Biotech position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 2,208 Trinity Biotech shares in Q2 2025, an estimated $37K.
  • HRT Financial first reported a position in Trinity Biotech in Q2 2020 and held it in 7 quarters.
  • HRT Financial's Trinity Biotech position peaked at $78K in Q3 2020.
  • 21 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.